These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


325 related items for PubMed ID: 11471024

  • 21. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC, Yulugkural Z, Vahaboglu H.
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [Abstract] [Full Text] [Related]

  • 22. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
    Xie Y, Zhao H, Dai WS, Xu DZ.
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M, Zhou X, Wei L, Qiu S, Zhou T, Li L, Gu X, Luo M, Zheng X.
    Virol J; 2007 Sep 24; 4():93. PubMed ID: 17892580
    [Abstract] [Full Text] [Related]

  • 24. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F.
    Am J Gastroenterol; 2005 Apr 24; 100(4):856-61. PubMed ID: 15784032
    [Abstract] [Full Text] [Related]

  • 25. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS, Perez RM, Medina-Pestana JO, Figueiredo MS, Koide S, Alberto FL, Silva AE, Ferraz ML.
    J Med Virol; 2006 Oct 24; 78(10):1284-8. PubMed ID: 16927290
    [Abstract] [Full Text] [Related]

  • 26. Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report.
    Lu SC, Yan LN, Li B, Ma YK, Liu C, Wen TF, Lin QY, Zhao JC, Wang XB, Li XD, Qing S, Zhao LS, Liu C, Liu J, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2003 May 24; 2(2):196-201. PubMed ID: 14599968
    [Abstract] [Full Text] [Related]

  • 27. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
    Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F.
    Hepatology; 2000 Nov 24; 32(5):1106-10. PubMed ID: 11050062
    [Abstract] [Full Text] [Related]

  • 28. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
    Zhang K, Imazeki F, Fukai K, Arai M, Kanda T, Mikata R, Yokosuka O.
    J Med Virol; 2007 Jun 24; 79(6):683-93. PubMed ID: 17457922
    [Abstract] [Full Text] [Related]

  • 29. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep 24; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 30. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr 24; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M.
    Clin Infect Dis; 2007 May 01; 44(9):1161-9. PubMed ID: 17407033
    [Abstract] [Full Text] [Related]

  • 33. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec 01; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 34. [Dynamics of HBV-DNA level in acute hepatitis B].
    Zhao H, Cao JH, Tian GS.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun 01; 17(2):159-61. PubMed ID: 12870000
    [Abstract] [Full Text] [Related]

  • 35. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 01; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 36. [Nucleic acid quantifying assay of hepatitis B virus].
    Zhang L, Zhu J, Ma Y, Zhang H.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb 01; 10(1):49-51. PubMed ID: 11856504
    [Abstract] [Full Text] [Related]

  • 37. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
    Galli C, Orlandini E, Penzo L, Badiale R, Caltran G, Valverde S, Gessoni G.
    J Med Virol; 2008 Jun 01; 80(6):974-9. PubMed ID: 18428144
    [Abstract] [Full Text] [Related]

  • 38. [Correlation of hepatitis B e antigen with hepatitis B virus DNA in the serum of chronic hepatitis B patients after treatment].
    Dou YL, Ni AP, Han JH, Sun JY, Yu RR.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 05; 86(33):2348-51. PubMed ID: 17156634
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].
    Zhang XD, Ren S, Yu HB, Liu YL, Jin Y, Huang YX, Chen JM, Chen XY.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep 05; 19(9):674-7. PubMed ID: 22152382
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.